uploads///flowers _

Cannabis Stock INSYS Therapeutics Has Risen 28% in January


Jan. 11 2019, Updated 3:26 p.m. ET

Stock performance

On January 10, INSYS Therapeutics stock closed at $4.49, which represents ~28% growth from its stock price of $3.50 at the close of market on December 31. On January 2, 2019, INSYS Therapeutics stock price grew ~24.29% to reach $4.35 from its prior day close of $3.50 on December 31, 2018.

On January 4, the company’s stock price grew ~4.42% to reach $4.25 from its prior day close of $4.07 on January 3, 2019. Its price on January 10 was a 34% increase from its 52-week low of $3.35 on December 28. The company hit its 52-week high of $11.65 on August 30, 2018.

Article continues below advertisement

About INSYS Therapeutics

INSYS Therapeutics focuses on the development and commercialization of novel drugs and novel drug delivery systems utilizing its proprietary spray technology and competence in developing cannabinoid pharmaceuticals.

Analysts’ recommendations

Of the five analysts tracking INSYS Therapeutics in January 2019, two of them recommended a “strong buy,” while two analysts recommended a “buy” rating. One analyst recommended a “sell” rating for INSYS Therapeutics. On January 11, INSYS Therapeutics had a consensus 12-month target price of $8.4, which represents ~87.08% return on investment over the next 12 months.

Peers’ ratings

In January 2019, of the five analysts tracking Zynerba Pharmaceuticals (ZYNE), 80% of them recommended some form of a “buy” rating and among the 13 analysts tracking GW Pharmaceuticals (GWPH), ~85% of them recommended some form of a “buy” rating.

On January 10, Zynerba Pharmaceuticals (ZYNE) and GW Pharmaceuticals (GWPH) had consensus 12-month target prices of $18.4 and $173.17, respectively, which represents ~341.25% and ~38.16% returns on investment over the next 12 months.


More From Market Realist

  • Michelob Ultra beer
    Company & Industry Overviews
    AB InBev Is the Top Beer Brand Worldwide—Is It a Monopoly?
  • Businesswoman looking out a window
    Company & Industry Overviews
    Shifting Focus: Three Women Investing Funds in 2021
  • Aol logo on office building,
    Company & Industry Overviews
    What We Know About Apollo Global Management, New Owners of AOL and Yahoo
  • Chick-fil-A sign
    Company & Industry Overviews
    Why It Only Costs $10K to Own a Chick-fil-A Location
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.